医疗诊断公司窥得儿医药（QDEL）今日盘前大涨10.90%，引起市场广泛关注。这一显著涨幅主要受益于公司最新发布的季度财报业绩大幅超出市场预期。
根据公司公布的财报显示，截至6月30日的季度中，窥得儿医药调整后每股收益达0.12美元，远超分析师平均预期的0.01美元。尽管公司营收同比小幅下降3.6%至6.139亿美元，但仍高于分析师预期的6.112亿美元。这一亮眼的业绩表现无疑提振了投资者信心，推动股价大幅上涨。
值得注意的是，窥得儿医药今年以来的股价表现并不理想，截至本季度末累计下跌45.9%。然而，华尔街分析师对公司前景仍持乐观态度。目前，分析师对该公司股票的平均评级为"买入"，12个月目标价中位数为50.00美元，较最新收盘价24.11美元高出约51.8%。这次超预期的季度业绩可能成为公司股价反弹的重要催化剂，但投资者仍需密切关注公司未来的业务发展和市场表现。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.